nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Application of the systematic review and bibliometric network analysis (SeBriNA) methodology contextualizes evidence. Part 2: rituximab for non-Hodgkin's lymphoma
|
Kho, Michelle E. |
|
2012 |
65 |
9 |
p. 996-1009 14 p. |
artikel |
2 |
A simple adaptation method improved the interpretability of prediction models for composite end points
|
Gondrie, Martijn J.A. |
|
2012 |
65 |
9 |
p. 946-953 8 p. |
artikel |
3 |
Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement
|
Hoy, Damian |
|
2012 |
65 |
9 |
p. 934-939 6 p. |
artikel |
4 |
A survey of physicians show a one-third reduction in harmful outcomes to be a clinically important difference for statin therapy
|
Li, Kathy K. |
|
2012 |
65 |
9 |
p. 954-961 8 p. |
artikel |
5 |
Be specific and dare to generalize: Do we need a rating form for every disease?
|
Kane, Robert L. |
|
2012 |
65 |
9 |
p. 921-923 3 p. |
artikel |
6 |
Classification and codification of rare diseases
|
Kodra, Yllka |
|
2012 |
65 |
9 |
p. 1026-1027 2 p. |
artikel |
7 |
Editorial Board
|
|
|
2012 |
65 |
9 |
p. IFC- 1 p. |
artikel |
8 |
Estimates of prospective change in self-rated health in older people were biased owing to potential recalibration response shift
|
Galenkamp, Henrike |
|
2012 |
65 |
9 |
p. 978-988 11 p. |
artikel |
9 |
How many risks-of-bias and comorbidity scales do we need?
|
Tugwell, Peter |
|
2012 |
65 |
9 |
p. 919-920 2 p. |
artikel |
10 |
Optimization of literature searching
|
Plevier, Josepha W.M. |
|
2012 |
65 |
9 |
p. 1027-1028 2 p. |
artikel |
11 |
Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes
|
Gnjidic, Danijela |
|
2012 |
65 |
9 |
p. 989-995 7 p. |
artikel |
12 |
Review of methods used to measure comorbidity in cancer populations: No gold standard exists
|
Sarfati, Diana |
|
2012 |
65 |
9 |
p. 924-933 10 p. |
artikel |
13 |
Table of Contents
|
|
|
2012 |
65 |
9 |
p. A3-A4 nvt p. |
artikel |
14 |
The “Child Health Evidence Week” and GRADE grid may aid transparency in the deliberative process of guideline development
|
Opiyo, Newton |
|
2012 |
65 |
9 |
p. 962-969 8 p. |
artikel |
15 |
The systematic review and bibliometric network analysis (SeBriNA) is a new method to contextualize evidence. Part 1: description
|
Kho, Michelle E. |
|
2012 |
65 |
9 |
p. 1010-1015 6 p. |
artikel |
16 |
Treatment effects on patient-important outcomes can be small, even with large effects on surrogate markers
|
Walter, Stephen D. |
|
2012 |
65 |
9 |
p. 940-945 6 p. |
artikel |
17 |
Unfolding the phenomenon of interrater agreement: a multicomponent approach for in-depth examination was proposed
|
Slaug, Björn |
|
2012 |
65 |
9 |
p. 1016-1025 10 p. |
artikel |
18 |
Web-based data collection yielded an additional response bias—but had no direct effect on outcome scales
|
Mayr, Andreas |
|
2012 |
65 |
9 |
p. 970-977 8 p. |
artikel |